This research demonstrates enhanced neurotransmitter detection using nanomaterials in neural systems, implying significant advancements in diagnosis.
All forms of neural communications, from cognition to emotion, are regulated by neurotransmitters, which are otherwise the chemical language of the brain. Precise detection of these neurotransmitters is essential for the perception of neurophysiology and diagnosis of neurodegenerative diseases as well. Among the existing techniques for the detection of these molecules, fluorescence sensing is evolving as a powerful approach in terms of high sensitivity, rapid response, and real-time visualization of the chemical events occurring in the neural system. In recent years, nanomaterials have transformed this field by integrating tunable optical properties, excellent photostability, and modifiable surface chemistry into biocompatible nanostructures. We summarize the recent advances of these architectures to show how the material type and dimensionality, as well as the surface functionality, play roles in sensing through the mechanisms of Förster resonance energy transfer (FRET), photoinduced electron transfer (PET), inner filter effect (IFE), and aggregation-induced emission (AIE). The discussion has also been extended to the correlation of fluorescence modulation with the selectivity and sensitivity in the mechanism-to-function relationship. The potential utility of such innovative technologies, including artificial intelligence, spectral deconvolution analysis via big data algorithms, and chip-integrated sensing, was explored as a means to enable real-time neurochemical detection. This converging area of nanotechnology and neuroscience leaves a mark not just in analytical accuracy, but also parallels human brain rhythms.
No takes yet. Share an insight, caveat, or question.
Durgadevi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: